Neuroleptic malignant syndrome induced by lamotrigine

Clinical Neuropharmacology

Volumn 36, Issue 4, 2013, Pages 131-132

  Ishioka, Masamichi ^a   Yasui Furukori, Norio ^a   Hashimoto, Kojiro ^a   Sugawara, Norio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Lamotrigine; Neuroleptic malignant syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; AMANTADINE; AMOXAPINE; ARIPIPRAZOLE; BACLOFEN; C REACTIVE PROTEIN; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; CREATINE KINASE; FLUPHENAZINE; HALOPERIDOL; LAMOTRIGINE; LEVODOPA; LINEZOLID; LITHIUM; METOCLOPRAMIDE; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PROCHLORPERAZINE; RINGER SOLUTION; RISPERIDONE; SERTRALINE; VALPROIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIPOLAR I DISORDER; BLOOD PRESSURE; CASE REPORT; DEPRESSION; DIAPHORESIS; DIARRHEA; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSPHAGIA; ELECTROCONVULSIVE THERAPY; FEVER; HEART RATE; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MALE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RIGIDITY; SIDE EFFECT; TREATMENT WITHDRAWAL; TREMOR;

EID: 84880813596     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e318294799a     Document Type: Article

References (13)

1. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41: 79-83.
2. Buckley PF, Hutchinson M. Neuroleptic malignant syndrome. J Neurol Neurosurg Psychiatry 1995;58(3): 271-273.
3. Anglin RE, Rosebush PI, Mazurek MF. Neuroleptic malignant syndrome: a neuroimmunologic hypothesis. CMAJ 2010;182(18): E834-E838.
4. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164: 6.
5. Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143: 1227-1233.
6. Jahan MS, Farooque AI, Wahid Z. Neuroleptic Malignant Syndrome. J Natl Med Assoc 84(11): 966-970.
7. Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs 2009;23(6): 477-492.
8. Wheless JW, Clarke DF, Arzimanoglou A, et al. Treatment of pediatric epilepsy: European expert opinion 2007. Epileptic Disord 2007;9: 353-412.
9. Muck-Seler D, Sagud M, Mustapic M, et al. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression. Neuropsychopharmacol Biol Psychiatry 2008;32: 1195-1198.
10. Samson-Fang L, Gooch J, Norlin C. Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol 2000;42: 561-565.
11. Patel MK, Brunetti L. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient. Am J Health Syst Pharm 2010;67(15): 1254-1259.
12. Palakurthi HB, Parvin MM, Kaplan S. Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient. Clin Neuropharmacol 2007;30(1): 47-51.
13. Serrano-Duenas M. Neuroleptic malignant syndrome-like, or-dopaminergic malignant syndrome-due to levodopa therapy withdrawal. Clinical features in 11 patients. Parkinson Relat Disord 2003;9: 175-178.